Vol 11, No 4 (2017)
Review paper
Published online: 2018-02-28

open access

Page views 640
Article views/downloads 14315
Get Citation

Connect on Social Media

Connect on Social Media

Emergencies in palliative care — clinical practice based on evidence

Izabela Anna Bętkowska1, Zbigniew Zylicz2
Medycyna Paliatywna w Praktyce 2017;11(4):153-165.

Abstract

Treatment of emergencies in palliative medicine aims mainly to improve quality of life more rarely pro­long survival. Doctors and nurses working in palliative care should conduct an appropriate assessment of the clinical situation and start appropriate treatment according to current knowledge, ethical standards with most benefits provided to patients and caregivers. In this article the most common emergencies in palliative care: circulatory, nervous, alimentary, urinary, respiratory and skeletal systems and metabolic, haematology and psychiatric disturbances were discussed. Drugs used in emergencies that doctor should have with them on home visit or in stationary hospice and in hospital were proposed.

Article available in PDF format

View PDF (Polish) Download PDF file

References

  1. Twycross R. The 'principle', not 'doctrine' of double effect. Int J Palliat Nurs. 2003; 9(1): 40.
  2. Zylicz Z. Ethical considerations in the treatment of pain in a hospice environment. Patient Educ Couns. 2000; 41(1): 47–53.
  3. Murray SA, Kendall M, Boyd K, et al. Illness trajectories and palliative care. BMJ. 2005; 330(7498): 1007–1011.
  4. Patel MI, Bhattacharya J, Asch SM, et al. Acceptance of Advance Directives and Palliative Care Referral for Veterans With Advanced Cancer: A Retrospective Analysis. Am J Hosp Palliat Care. 2016; 33(8): 742–747.
  5. Lesperance M, Shannon R, Pumphrey PK, et al. Training mid-level providers on palliative care: bringing advanced directives and symptom assessment and management to community oncology practices. Am J Hosp Palliat Care. 2014; 31(3): 237–243.
  6. Donnellan E, Khorana AA. Cancer and Venous Thromboembolic Disease: A Review. Oncologist. 2017; 22(2): 199–207.
  7. Shankar VK, Handa A, Hands L. Endogenous heparin activity is decreased in peripheral arterial occlusive disease. J Vasc Surg. 2008; 47(5): 1033–1038.
  8. Sheard L, Prout H, Dowding D, et al. The ethical decisions UK doctors make regarding advanced cancer patients at the end of life--the perceived (in) appropriateness of anticoagulation for venous thromboembolism: a qualitative study. BMC Med Ethics. 2012; 13: 22.
  9. Tuneu A, Moreno A, de Moragas JM. Cutaneous reactions secondary to heparin injections. J Am Acad Dermatol. 1985; 12(6): 1072–1077.
  10. Noble S, Matzdorff A, Maraveyas A, et al. Assessing patients' anticoagulation preferences for the treatment of cancer-associated thrombosis using conjoint methodology. Haematologica. 2015; 100(11): 1486–1492.
  11. Wells PS, Anderson DR, Rodger M, et al. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb Haemost. 2000; 83(3): 416–420.
  12. Flores J, García de Tena J, Galipienzo J, et al. Clinical usefulness and safety of an age-adjusted D-dimer cutoff levels to exclude pulmonary embolism: a retrospective analysis. Intern Emerg Med. 2016; 11(1): 69–75.
  13. Clemens KE, Klaschik E. Dyspnoea associated with anxiety--symptomatic therapy with opioids in combination with lorazepam and its effect on ventilation in palliative care patients. Support Care Cancer. 2011; 19(12): 2027–2033.
  14. Wharin C, Tagalakis V. Management of venous thromboembolism in cancer patients and the role of the new oral anticoagulants. Blood Rev. 2014; 28(1): 1–8.
  15. Ferreira DH, Silva JP, Quinn S, et al. Blinded Patient Preference for Morphine Compared to Placebo in the Setting of Chronic Refractory Breathlessness--An Exploratory Study. J Pain Symptom Manage. 2016; 51(2): 247–254.
  16. Hsu JW, Chiang CD, Hsu WH, et al. Superior vena cava syndrome in lung cancer: an analysis of 54 cases. Gaoxiong Yi Xue Ke Xue Za Zhi. 1995; 11(10): 568–573.
  17. Terasaki K, Ohkubo K, Kanekura T. Facial edema as a clue to superior vena cava syndrome associated with lung cancer. Eur J Dermatol. 2012; 22(4): 546–547.
  18. Tsao MN, Lloyd N, Wong RKS, et al. Whole brain radiotherapy for the treatment of multiple brain metastases. Cochrane Database Syst Rev. 2006(3): CD003869.
  19. Yamashiro S, Hitoshi Y, Tajiri S, et al. Palliative lumboperitoneal shunt for leptomeningeal metastasis-related hydrocephalus: A case series. Palliat Med. 2017; 31(1): 93–96.
  20. Keats AS, Mithoefer JC. The mechanism of increased intracranial pressure induced by morphine. N Engl J Med. 1955; 252(26): 1110–1113.
  21. Sachs B. [Epileptic seizure as a symptom of intracranial tumor]. Z Arztl Fortbild (Jena). 1987; 81(3): 131–132.
  22. Patsalos PN, Fröscher W, Pisani F, et al. The importance of drug interactions in epilepsy therapy. Epilepsia. 2002; 43(4): 365–385.
  23. Fainsinger RL, Spachynski K, Hanson J, et al. Symptom control in terminally ill patients with malignant bowel obstruction (MBO). J Pain Symptom Manage. 1994; 9(1): 12–18.
  24. Ritch CR, Poon SA, Sulis ML, et al. Cutaneous vesicostomy for palliative management of hemorrhagic cystitis and urinary clot retention. Urology. 2010; 76(1): 166–168.
  25. Maltoni M, Pittureri C, Scarpi E, et al. Palliative sedation therapy does not hasten death: results from a prospective multicenter study. Ann Oncol. 2009; 20(7): 1163–1169.
  26. Stewart AF. Clinical practice. Hypercalcemia associated with cancer. N Engl J Med. 2005; 352(4): 373–379.
  27. Larsen TR, Galthen-Sørensen M, Antonsen S. Ionized calcium measurements are influenced by albumin--should ionized calcium be corrected? Scand J Clin Lab Invest. 2014; 74(6): 515–523.
  28. Brown E, Bennett M. Survey of blood transfusion practice for palliative care patients in Yorkshire: implications for clinical care. J Palliat Med. 2007; 10(4): 919–922.
  29. Centeno C, Sanz A, Bruera E. Delirium in advanced cancer patients. Palliat Med. 2004; 18(3): 184–194.
  30. Carlson B. Delirium in patients with advanced cancer. Lancet Oncol. 2016; 17(9): e379.
  31. Neufeld KJ, Yue J, Robinson TN, et al. Antipsychotic Medication for Prevention and Treatment of Delirium in Hospitalized Adults: A Systematic Review and Meta-Analysis. J Am Geriatr Soc. 2016; 64(4): 705–714.
  32. Tanaka R, Ishikawa H, Sato T, et al. Incidence of Delirium Among Patients Having Cancer Injected With Different Opioids for the First Time. Am J Hosp Palliat Care. 2017; 34(6): 572–576.